8HVA

Crystal structure of EGFR_TMX in complex with covalently bound compound 14

8HVA の概要

• エントリーDOI: 10.2210/pdb8hva/pdb
• 分子名称: Epidermal growth factor receptor, ~{N}-[6-(1-methylindol-3-yl)pyrimidin-4-yl]prop-2-enamide (2 entities in total)
• 機能のキーワード: epidermal growth factor receptor kinase, covalent fragments, mutant egfr, anti-cancer, transferase
• 由来する生物種: Homo sapiens (human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 37811.64

構造登録者

Takahashi, M.,Dokurno, P. (登録日: 2022-12-26, 公開日: 2023-12-13, 最終更新日: 2024-04-03)

• 主引用文献: Kuki, N.,Walmsley, D.L.,Kanai, K.,Takechi, S.,Yoshida, M.,Murakami, R.,Takano, K.,Tominaga, Y.,Takahashi, M.,Ito, S.,Nakao, N.,Angove, H.,Baker, L.M.,Carter, E.,Dokurno, P.,Le Strat, L.,Macias, A.T.,Molyneaux, C.A.,Murray, J.B.,Surgenor, A.E.,Hamada, T.,Hubbard, R.E.; A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinase.; Rsc Med Chem, 14:2731-2737, 2023; PubMed: 38107172; DOI: 10.1039/d3md00439b

実験手法

X-RAY DIFFRACTION (2.77 Å)